Recent Work Azur Pharmaceuticals
Share This

Azur Pharmaceuticals

Thursday, 11 March 2010

Advised Azur on the acquisition of the worldwide rights (other than Europe) to Prialt ® from Elan Pharmaceuticals Inc. which is used for the management of chronic pain in the USA. will offer employment to a 34 person specialty pharmaceutical infrastructure, which is currently supporting the product at Elan.